Literature DB >> 14719543

Two distinct subgroups of senile dementia of Alzheimer type: quantitative study of neurofibrillary tangles.

Yutaka Mizuno1, Kenji Ikeda, Kuniaki Tsuchiya, Ryoko Ishihara, Hiroto Shibayama.   

Abstract

The heterogeneity of senile dementia of Alzheimer type (SDAT) has been suggested by some authors clinically and neuropathologically. The heterogeneity of SDAT was investigated based on quantification of NFT combining Braak and Braak's neuropathological staging and the density of NFT in various areas of the cerebral cortex. Brain tissues were examined from 16 autopsy cases with clinically late onset dementia (> age 65) and neuropathologically diagnosed dementia of Alzheimer type (DAT). Gallyas-Braak staining was used for the quantification of NFT. The density of NFT was examined in the precentral gyrus, middle temporal gyrus (T2), parahippocampal gyrus and the amygdaloid nucleus. The 16 cases studied were divided into two groups depending on the number of NFT in the cortex (cut-off score: 5/mm2): the AD-like group (NFT > or = 5/mm2) and the common group (NFT < 5/mm2). The density of NFT in the precentral gyrus (t(3.225) = -9.007, P = 0.002) and T2 (t(3.365) = -3.774, P = 0.027) in the AD-like group was significantly higher than those in the common group. However, no significant difference was observed in the parahippocampal gyrus between the two groups (t(14) = -0.318, NS). Moreover, there were no significant differences between the two groups as regards age at onset and the duration of the illness. The present study revealed the possible existence of two subgroups in SDAT having significantly different NFT densities in various areas of the cerebral cortex without any significant difference in their duration of illness. This classification has no relationship to Braak and Braak's staging, which depends only on the distribution of NFT, irrespective of their density. Arai et al. revealed that the NFT density in AD was significantly higher than in SDAT. We suggest that the neuropathological findings of the AD-like group in SDAT resemble those of presenile AD.

Entities:  

Mesh:

Year:  2003        PMID: 14719543     DOI: 10.1046/j.1440-1789.2003.00514.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  8 in total

1.  Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.

Authors:  Raffaella Migliaccio; Federica Agosta; Katherine L Possin; Elisa Canu; Massimo Filippi; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  "End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?

Authors:  Erin L Abner; Richard J Kryscio; Frederick A Schmitt; Karen S Santacruz; Gregory A Jicha; Yushun Lin; Janna M Neltner; Charles D Smith; Linda J Van Eldik; Peter T Nelson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 3.  Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD.

Authors:  Mark W Jacobson; Linda K McEvoy; Anders Dale; Christine Fennema-Notestine
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

4.  MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.

Authors:  J L Whitwell; K A Josephs; M E Murray; K Kantarci; S A Przybelski; S D Weigand; P Vemuri; M L Senjem; J E Parisi; D S Knopman; B F Boeve; R C Petersen; D W Dickson; C R Jack
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

5.  Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease.

Authors:  Gustavo Basurto-Islas; Jose Luna-Muñoz; Angela L Guillozet-Bongaarts; Lester I Binder; Raul Mena; Francisco García-Sierra
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

6.  Exercise and early-onset Alzheimer's disease: theoretical considerations.

Authors:  Astrid M Hooghiemstra; Laura H P Eggermont; Philip Scheltens; Wiesje M van der Flier; Erik J A Scherder
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-04-14

7.  IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.

Authors:  Oznur Bayraktar; Ozlem Oral; Nur Mehpare Kocaturk; Yunus Akkoc; Karin Eberhart; Ali Kosar; Devrim Gozuacik
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

8.  The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease.

Authors:  So-Hee Park; Eun-Hye Lee; Hyung-Ji Kim; Sungyang Jo; Sunju Lee; Sang Won Seo; Hyun-Hee Park; Seong-Ho Koh; Jae-Hong Lee
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.